Massive Hemorrhage
10
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Point of Care Fibrinogen Measurement in Trauma Patients in the Emergency Department
Calcium Administration in Life-saving Management During Massive Hemorrhage
Study to Actively Warm Trauma Patients-2
Initial Resuscitation With Albumin in Hemorrhagic Shock to Reduce Positive Fluid Balance
Factor In the Initial Resuscitation of Severe Trauma 2 Patients
Prediction of Massive Transfusion in Trauma Patients
Patient Blood Management for Massive Obstetric Hemorrhage
Use of Viscoelastic Tests in the Treatment of Traumatic Induced Coagulopathy: a Pragmatic Randomized Clinical Trial.
Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia
Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)